Core Viewpoint - The announcement details the issuance of shares and cash payment for asset acquisition by China National Materials International Engineering Co., Ltd., including the listing of restricted shares for trading. Group 1: Share Issuance and Listing - The type of stock listing is a non-public offering, with a total of 366,878,106 shares to be listed [2][3] - The listing date for the restricted shares is set for March 2, 2026 [4] Group 2: Asset Acquisition and Lock-up Period - In February 2023, the company received approval from the China Securities Regulatory Commission to issue shares to acquire assets from the China Building Materials Academy, resulting in the issuance of 366,878,106 shares [5] - The shares acquired by the China Building Materials Academy will be subject to a lock-up period of 36 months, with potential extensions based on stock performance [5] Group 3: Changes in Share Capital - As of April 10, 2023, the company completed the registration of 9,807,253 shares from its 2021 restricted stock incentive plan, increasing total shares to 2,642,317,423 [7] - The company has undergone several share buybacks, reducing total shares to 2,621,819,524 as of the announcement date [8][9] Group 4: Compliance and Verification - The shareholders of the restricted shares have fulfilled their commitments regarding the listing of these shares [9] - The independent financial advisor, Huatai United Securities, confirmed compliance with relevant regulations regarding the release of restricted shares [11]

Group 1 - The company has approved the use of idle raised funds for cash management, allowing up to 350 million yuan to be invested in low-risk, liquid financial products [2][3] - The company purchased structured deposits from Zheshang Bank and cash management products from China Galaxy Securities, each amounting to 40 million yuan [3] - The company has redeemed these financial products recently, indicating effective cash management practices [3] Group 2 - The company raised a total of 350.58 million yuan through a non-public offering of shares, with a net amount of 344.49 million yuan after deducting issuance costs [7] - The company has established a special account for the raised funds and signed four-party and five-party supervision agreements to ensure proper management and usage of the funds [10][16] - The agreements stipulate that the funds can only be used for the designated project, the 120MW/240MWh user-side energy storage project, and outline the responsibilities of all parties involved [12][18]

Group 1 - The company has participated in the bidding for the construction of the Weifang to Zoucheng Expressway, specifically the Yiyuan to Zoucheng section and the Changle connection line, which has been approved by the board and shareholders [2][3][40] - The total bid amount for the Yiyuan to Zoucheng section is approximately 9.4 billion yuan, while the bid for the Changle connection line is approximately 1.4 billion yuan [3][40] - The company has signed investment contracts with the bidding entity, Shandong High-speed Infrastructure Construction Co., Ltd., for both projects [4][40] Group 2 - The total estimated cost for the Yiyuan to Zoucheng section project is approximately 1.74 billion yuan, with the company contributing 74.23% of the capital [7][40] - The total estimated cost for the Changle connection line project is approximately 272.99 million yuan, with the company contributing 74.94% of the capital [25][40] - The investment contracts outline the governance structure, rights, and obligations of the parties involved, ensuring that the company maintains control over project management and financial oversight [11][39][40] Group 3 - The execution of the investment contracts is expected to positively impact the company's main business revenue and operational performance, aligning with its strategic goals [40] - The company has undergone necessary approvals from independent directors and board meetings to validate the transactions [42][40] - The contracts include provisions for profit distribution based on the actual capital contributions of each party involved [18][35]

Financial Performance - In 2025, the company achieved operating revenue of 565.38 million yuan, an increase of 18.33% compared to the previous year [2] - The net loss attributable to the parent company was 26.38 million yuan, a reduction in loss of 67.85% year-on-year [2] - Total assets at the end of 2025 were 1.75 billion yuan, a year-on-year increase of 9.33% [2] SaaS Business Development - The company's SaaS product revenue showed stable growth, with ongoing optimization of services for small and medium-sized merchants [3] - The large merchant SaaS product development and market layout have matured, leading to increased customer satisfaction and market recognition [3] - The company extended its e-commerce SaaS business into procurement and supply chain management, providing new growth opportunities [3] Stock Incentive Plan - The company approved the grant of 300,000 restricted stocks at a price of 6.91 yuan per share to three incentive objects on February 13, 2026 [8][70] - The stock grant is part of the 2025 restricted stock incentive plan, which aims to attract and retain talent while aligning the interests of employees and shareholders [14][70] Investment Management - The company plans to use up to 300 million yuan of idle self-owned funds for entrusted wealth management, focusing on high-security and high-liquidity financial products [27][30] - The investment aims to improve fund utilization efficiency without affecting the company's main business operations [39] Credit and Guarantee - The company intends to apply for a comprehensive credit limit of up to 1.5 billion yuan from banks or financial institutions, providing guarantees for its wholly-owned subsidiaries [75] - The guarantee amount is capped at 300 million yuan, with the aim of supporting the subsidiaries' operational and project financing needs [76]

Group 1 - The company held its 23rd meeting of the 9th Board of Directors on February 13, 2026, where all 9 directors attended and the meeting complied with relevant laws and regulations [2][12] - The Board approved the amendment to the Articles of Association, changing the registered capital from 323,270,000 yuan to 484,905,000 yuan due to the implementation of the restructuring plan [3][14] - The Board also approved the expected daily related transactions for 2026, with a total amount not exceeding 145.5235 million yuan [5][18] Group 2 - The company plans to hold the first extraordinary general meeting of 2026 on March 5, 2026, to review the approved proposals [11][55] - The Board approved a proposal to provide guarantees for its subsidiary, with a maximum guarantee amount of 49.47 million yuan for a bank loan of 97 million yuan [39][41] - The independent directors unanimously agreed that the guarantee for the subsidiary aligns with the company's long-term development and does not harm the interests of shareholders [50][48]

Group 1 - The company held its 29th meeting of the 11th Board of Directors on February 13, 2026, to discuss various proposals, including financing and guarantees for subsidiaries [2][3][4] - The Board approved a financing limit of 3 billion yuan for 2026, which includes bank loans, leasing, and other financing methods [4][15] - The Board also approved an additional guarantee limit of 3.5 billion yuan for subsidiaries, with 3 billion yuan allocated for financing guarantees and 500 million yuan for contract performance guarantees [4][15] Group 2 - The company plans to provide financial assistance to its subsidiaries, including a loan of up to 100 million yuan to Xingtai Xuyang New Energy Technology Co., Ltd. and recognition of a previous loan of 200 million yuan to Inner Mongolia Xiangfu New Energy Co., Ltd. as financial assistance [7][39][40] - The financial assistance is aimed at supporting the daily operations and project developments of the subsidiaries, which are engaged in lithium battery material research and production [40][54] - The Board believes that the financial assistance poses controllable risks and does not harm the interests of the company or its minority shareholders [55][56] Group 3 - The company approved the signing of EPC contracts for two projects: a 1,000 tons/year porous carbon project with an estimated contract value of 120 million yuan and a 2,000 tons/year silicon-carbon negative material project with an estimated contract value of 300 million yuan [8][62][70] - The contractors for these projects are controlled by the company's major shareholder, which constitutes related party transactions [9][73] - The Board confirmed that these transactions are within the normal business scope and do not adversely affect the company's operations or independence [73][74] Group 4 - The company will hold its second extraordinary general meeting of 2026 on March 2, 2026, to discuss the proposals approved by the Board [10][81] - The meeting will include provisions for both on-site and online voting, ensuring compliance with relevant laws and regulations [82][83] - Shareholders and their proxies will have the right to attend and vote at the meeting, with specific arrangements for related party transactions [84][86]

Group 1 - The core point of the news is that China Pacific Asset Management Co., Ltd. has decided to hold a communication-based meeting for the fund holders of the "PICC Minrui 30-Day Rolling Bond Fund" to discuss the termination of the fund contract [1][5][25] - The meeting will be conducted via communication methods, with voting starting from February 12, 2026, to March 12, 2026, at 17:00 [2][6] - The meeting aims to review the proposal to terminate the fund contract due to changes in market conditions and to better protect the interests of fund holders [25][29] Group 2 - The rights registration date for fund holders to participate in the meeting is February 12, 2026 [6] - Voting methods include submitting ballots by mail or telephone voting, with specific instructions provided for both individual and institutional investors [7][14] - The voting results will be counted by authorized supervisors under the supervision of the fund custodian, with a requirement that at least two-thirds of the voting rights must be in favor for the resolution to pass [17][22] Group 3 - The fund will enter a liquidation process immediately after the resolution is passed, and no new subscriptions or redemptions will be accepted during this period [30] - The liquidation process will involve a series of steps including asset evaluation, debt settlement, and distribution of remaining assets to fund holders based on their shareholding [30][34] - The fund management has prepared for the termination and liquidation, ensuring compliance with legal and operational requirements [38][39]

公告送出日期：2026年02月14日 1、 公告基本信息 ■ 注：浙江浙商证券资产管理有限公司决定自2026年02月24日（含2026年02月24日）起恢复办理浙商汇金 锦利增强30天持有期债券型证券投资基金100万元以上的大额申购业务，敬请投资者留意。 2、 其他需要提示的事项 浙江浙商证券资产管理有限公司 2026年02月14日 浙商汇金短债债券型证券投资基金恢复大额 申购公告 （1）本公告仅对本基金恢复大额申购的有关事项予以说明。投资者欲了解本基金的详细情况，请查询 本基金的《基金合同》和《招募说明书》。 公告送出日期：2026年02月14日 （2）投资者可以登陆浙江浙商证券资产管理有限公司网站www.stocke.com.cn或拨打浙江浙商证券资产 管理有限公司客户服务热线95345进行相关咨询。 1、 公告基本信息 （3）风险提示：基金管理人承诺以诚实信用、勤勉尽责的原则管理和运用基金资产，但不保证基金一 定盈利，也不保证最低收益。基金管理人提醒投资者基金投资的"买者自负"原则，在做出投资决策后， 基金运营状况与基金净值变化引致的投资风险，由投资者自行负担，投资者投资于本基金前应认真阅读 本基金的《 ...

Core Viewpoint - The company, Jinan Shengquan Group Co., Ltd., plans to acquire a 13.50% stake in its subsidiary, Jinan Shangbo Pharmaceutical Co., Ltd., from BIOSYNTH LIMITED for a total consideration of $4.29 million, increasing its ownership from 76.50% to 90.00% [2][4][30]. Group 1: Transaction Overview - The acquisition aims to enhance the synergy between fine chemicals and pharmaceutical intermediates, improve asset integration efficiency, and optimize the governance structure of the subsidiary [4]. - The transaction has been approved by the company's board of directors and does not require shareholder approval as it does not meet the threshold for such a review [3][31][32]. - The total transaction amount is $4.29 million, which is based on an asset valuation report that assessed the market value of the subsidiary's equity at approximately ¥222.92 million [14][22]. Group 2: Related Party Transaction - BIOSYNTH LIMITED is considered a related party due to the prior directorship of Wang Wubao, who served as a director at both the company and BIOSYNTH [2][7]. - The company has not engaged in similar transactions with different related parties in the past 12 months, and the cumulative amount of daily related transactions with the same related party is ¥17.57 million [6][34]. Group 3: Financial and Operational Aspects - Shangbo Pharmaceutical focuses on CDMO services for pharmaceutical intermediates, providing integrated services for the development and production of small molecule intermediates [10]. - The subsidiary has passed various international certifications, including FDA approval, and operates under EU CGMP standards [10]. Group 4: Approval Process - The transaction was reviewed and approved in a special meeting of independent directors before being presented to the full board, where it received unanimous support [5][31].

证券代码：601865 证券简称：福莱特 公告编号：2026-009 转债代码：113059 转债简称：福莱转债 福莱特玻璃集团股份有限公司 关于公司高级管理人员辞职的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 福莱特玻璃集团股份有限公司（以下简称"公司"）董事会近日收到公司副总裁赵长海先生提交的辞职报 告。赵长海先生因个人原因，提请辞去公司副总裁职务。赵长海先生辞去上述职务后，仍负责子公司光 伏玻璃的生产管理工作。 根据《公司法》《公司章程》等有关规定，赵长海先生的辞职报告自送达公司董事会之日起生效，其辞 职不会影响公司正常的生产经营和管理。 赵长海先生在公司担任副总裁期间恪尽职守、勤勉尽责，公司董事会对赵长海先生在任职期间为公司所 做出的贡献表示衷心的感谢！ 特此公告。 福莱特玻璃集团股份有限公司 董事会 二零二六年二月十四日 一、董事/高级管理人员离任情况 (一)提前离任的基本情况 ■ (二)离任对公司的影响 证券代码：601865 证券简称：福莱特 公告编号：2026-007 转债代码：113 ...